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Abstract 
In an evolutionary model, health and disease are regarded as successful and respectively failed adaptation to the demands of the 
environment. The social factors are critical for a successful adaptation, while emotions are means of both signaling the organism’s 
state and of adapting the physiological responses to environmental challenges. Hence the importance of a biopsychosocial model of 
health and disease. Psychoemotional distress generates and/or amplifies somatic symptoms. Somatization may be viewed as an 
altered cognitive process, inclining the individual to an augmented perception of bodily sensations and to an increased degree of 
complexity in reporting negative experiences (hence the greater cognitive effort allocated thereto). Somatosensory amplification and 
alexithymia are key elements in this process. The brain’s right hemisphere is more involved in the generation of emotionally 
conditioned somatization symptoms. Somatic symptoms have various psychological and social functions and are strongly influenced 
by the particular belief system of the individual. Inappropriately perceiving the environment as an aggressor and excessively 
responding to it (by activating the cytokine system in correlation with the arousal of the psychic, nervous, and endocrine systems) 
may be a key element in the altered cognition conducive to ill health. 
 
Keywords: somatoform disorders, unexplained physical symptoms, somatization,  
amplification, alexithymia, cognitive model, cytokine. 
Introduction 
The conventional medicine has no comprehensive 
theory about the meaning of some fundamental concepts, 
such as health, predisposition to disease (to ill health) and 
disease. One cannot miss the correlation with an old 
dilemma of both philosophy and science: is the dichotomy 
mind-body correct or should those two be regarded as 
forming an inseparable unity. The current conventional 
explanations regarding the concept of illness are based 
on the pathological findings brought on by infection, 
substance poisoning, trauma and genetic mutation. The 
reason is the influence exerted by the precepts of 
classical physics upon the medical concepts, to which 
they have imparted a mechanistic, materialistic, 
deterministic, reductionist orientation, characterized by a 
linear cause-effect type of vision and a strong predilection 
to handy explanations about disease. Many attempts 
have been made lately to build a more comprehensive 
theory, able to integrate the present proven roles of 
physical, social, environmental, and psychological factors 
in disease predisposition, etiology, and pathogenesis. The 
psychic background might be viewed as either cause or 
effect and as either aggravating or accompanying factor 
of symptoms or physical illnesses. 
Evolutionary models 
Weiner talks about the necessity of an evolutionary 
vision, able to lead to a unified, integrated theory about 
health and disease and to a more clear taxonomy in 
medicine, taking as a start point Darwin’s theory, which 
asserts that evolution, is spurred by natural and sexual 
selection. Natural selection acts differently upon 
individuals according to their ability to adapt: those able to 
adapt survival to reproduce; failing to adapt reduces the 
aptitude to reproduce and to be successful, finally leading 
to disease or death. This formulation may be extrapolated 
to (the predisposition to) disease, which may be viewed 
as failed adaptation, whereas health would equate with 
successful adaptation.  
Adaptation is determined by multiple genetic, 
morphological, physiological and behavioral factors and 
allows the organism to accommodate with the multiple 
and varied selective pressures. There is evidence that 
primates with a social life (i.e. living in groups) have a 
selective advantage and are among the species with the Journal of Medicine and Life Vol. 2, No.4, October-December 2009 
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greatest evolutionary success. The social behavior (for 
instance, the social support) seems to increase the 
individual’s chances to survive and to be fit for 
reproduction. The physiological (immunological, 
metabolic, cardiovascular) and behavioral adaptations are 
specifically directed by interactions with the environment, 
while emotions have emerged on the evolutionary line as 
ways of signaling the state of the organism and of 
adapting the physiological responses to environmental 
challenges [1].  
Biopsychosocial models 
Efforts made for many decades regarding the aim of 
finding a unified concept of health and disease have been 
channeled toward developing a new medical model able 
to integrate psychic and social aspects in a 
biopsychosocial model (proposed originally by Engel). 
According to this model, comprehending pathological 
processes should rely upon understanding the interaction 
of three entities: the body (bio-), the mind (psycho-) and 
the social context. Therefore, the disease process should 
be approached from the perspective of a complex 
multifactorial model [2]. Not only a new model of disease 
is necessary, but also a new diagnosing system relying on 
the psychosomatic model, instead of the biomedical 
model of disease (upon which the diagnosing system 
currently used in the conventional medicine is based). 
Oken describes a multiaxial method, which allows a 
diagnosis formulation reflecting the adaptation process, 
including the biological, psychological and social factors. 
This approach may give rise to a momentous reform in 
medical care, reflecting the psychosomatic model of 
disease [3]. 
The original trend in psychosomatic medicine was to 
correlate the physical symptoms only with individual 
psychic aspects, disregarding the social environment the 
individual is living in. This approach is nowadays 
anachronic, and the resurrection of psychosomatic 
medicine depends precisely on this comprehensive vision 
upon the individual as part of the environment [4] – 
integrating the relationship between personality and the 
social matrix of somatic distress is critical in 
understanding the somatoform disorders [5]. 
Somatization is a universal phenomenon, identifiable in 
any culture or civilization [6]. There are significant 
differences in the somatization process, which are not 
leveled out by a health care system equally accessible to 
any ethnic group. Kirmayer and Young have proved that 
the somatic symptoms have various psychological and 
social functions and are strongly influenced by the 
particular system belief of the individual. Depending on 
the cultural, ethnic, religious, social, professional, and 
familial environment of the individual, the symptoms may 
be regarded as signifying: 
•  a physical disease; 
•  a functional disorder; 
•  a psychic illness; 
•  the outward expression of inner psychic 
tensions; 
•  a culturally coded expression of distress; 
•  a mean of channeling social dissatisfaction; 
•  a way o defining or redefining the individual’s 
position in relation to other people. 
Different ethnic groups have various 
cultural/historical/religious backgrounds, which are 
reflected in the: 
•  different ways of perceiving and expressing 
distress, including the bodily one; 
•  different sets of ethnomedical beliefs; 
•  different perceptions about the official health 
care system, its usefulness and its accessibility. 
Therefore, the vision about somatization should be 
broadened so as to take into account not only the 
individual characteristics, but also the social and cultural 
ones [7]. Thus we will be able to surpass the nosological 
limitations imposed by the current psychiatric theories [8]. 
Psychophysiological models  
Two terms are used in literature to designate 
somatization phenomena: somatoform disorders (SFD) 
and medically unexplained physical symptoms (MUPS). 
The general trend is to consider the two terms as 
completely interchangeable. 
Rief et al. found out that the most common somatoform 
symptoms are pain (primarily, back pain, joint pain, pain in 
extremities, and headache), abdominal symptoms 
(bloating or intolerance to several foods) and 
cardiovascular symptoms (palpitations) [10]. 
It is generally recognized the propensity of people with 
intense and/or persistent feelings to push the emotional 
distress towards a physical territory. Therefore, somatic 
distress may be viewed as a distinct psychological 
dimension [9]. Psycho behavioral characteristics have an 
important predictive value for SFD and should probably 
be used as positive diagnostic criteria for these disorders 
[11]. 
While exploring the psychology of physical symptoms, 
researchers have looked for various patterns of somatic 
displacement of trauma, frustrations and resentments. 
Psychophysiological models, based on the notion of 
combined effects (the psychic and physiological levels 
regarded as being in an indissociable interplay) [12] are 
increasingly accepted more at present. New paradigms 
are also necessary for defining the role of psychotherapy 
for the subjects with complex disorders and chronic 
symptoms [13]. 
Psychoemotional distress generates and/or amplifies 
somatic symptoms, but many other variables intervene in 
modulating their intensity and the manner they are 
perceived, interpreted, and reported by the patients – 
gender, race, and ethnic and cultural background are only Journal of Medicine and Life Vol. 2, No.4, October-December 2009 
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a few among them [14,  15, 16]. The result is the 
multifaceted polymorphism of somatization, although its 
mechanism seems to be in essence only one. This made 
some authors hypothesize that the apparently manifold 
somatoform syndromes might be considered as being one 
and the same under a variety of appearances [17].  
Gender seems to have an important bearing upon 
symptom perception. Kroenke and Spitzer have shown 
that most physical symptoms (either explained or 
unexplained by physical causes) are characteristically 
reported at least 50% more frequently by women than by 
men. The manner of reporting the symptoms is influenced 
most strongly by the concurrent depressive and/or 
anxious disorders (which are also more prevalent in 
women). However, the demographic factors have an 
independent effect too. Among these, gender is the most 
important, followed by the educational level. Age and race 
have a lesser effect, and so do medical comorbidities [18]. 
The severity of somatization is related to the 
personality traits and the psychiatric disorders [19]. Some 
of these originate in childhood: learning to adopt the sick 
role and being encouraged to do so in the first decade of 
life predicts the illness behavior during adulthood [20]. In 
fact, some researchers consider the somatoform 
disorders as being severe psychiatric diseases unduly 
disregarded by the psychiatrists, given their high 
prevalence in the general population [21]. 
Cognitive models 
The current tendency, born decades ago, is to 
perceive somatization as an altered cognitive process, 
which is the result of the interaction between the cognitive 
characteristics and the social ones [22]. The alteration of 
the cognitive process in patients with SFD can be 
demonstrated objectively by means of laboratory studies 
(for example, by using the technique of evoked response 
potentials, either auditory [23] or visual [24]). The 
somatization process may have its roots in or may be 
amplified by an altered perception of disease – therefore 
understanding this process requires an assessment of the 
cognitive representation of illness [25]. The alteration of 
the cognitive skills is reflected in the amplification of bodily 
sensations, which fuel the tendency to somatization and 
therefore the proneness to develop SFD [26] – hence, the 
recognized effectiveness of cognitive-behavioral therapies 
in the management of SFD [27], documented by many 
controlled clinical trials [28]. Interpreted from a cognitive-
psychobiological perspective, SFD may be explained 
through the readiness of somatization-prone persons to 
notice and remember physical symptoms, which might 
indicate certain psychological and psychophysiological 
mechanisms possibly involved in maintaining the SFD. It 
was shown (Rief et al.) that the patients with SFD (if 
compared with normal subjects) have a higher level of 
salivary cortisol, an increased cardiac frequency, and a 
lower digital pulse volume while executing a stress-
generating task; they also tend to report a higher degree 
of psychic distress [29]. 
The alteration of the cognitive processes is involved 
not only in the genesis of SFD, but also in the health state 
deterioration. Thus, health outcome is affected by the 
cognitive aspects generated by the negative emotional 
impact of recalling some unhappy events. This is related 
to the increased complexity of the cortical processes 
involved in the integration of the episodes in question, 
reflecting the amount of intellectual resources allocated to 
the management of those conditions or problems. 
Recalling negative experiences requires an increased 
cognitive effort, reminiscent of that induced by the original 
confrontation with the negative experiences. The cognitive 
involvement, both excessive and deficient, is associated 
with a diminished well-being sensation as compared with 
a moderate cognitive involvement. This has implications 
upon the manner in which the negative events are 
reconstituted in memory, upon the relationship between 
the cognitive processes and the emotional ones, as well 
as upon the relationship between cognitive processes and 
health state. In an effort to unravel whether very 
unpleasant life events are recalled at a different level of 
complexity than the neutral memories and whether the 
differences in complexity are correlated with the health 
outcome, Suedfeld and Pennebaker have asked 
volunteers to give written accounts about both negative 
life experiences, and trivial events. The investigators have 
compared the complexity scores of these two types of 
reports and have correlated them with an assessment of 
the well-being state. The reports about negative 
experiences have been significantly more complex, which 
implies greater cognitive effort allocated thereto. In the 
subjects who wrote about negative events, a significant 
relationship between the report’s complexity and the 
general state improvement was apparent [30]. Solano et 
al have reached similar results [31]. 
Lane points out the importance of emotional 
awareness, i.e. the subject’s ability to have a conscious 
grasp on his feelings and to be able to express them. 
Passing from the unconscious to the conscious level is 
seen as a gradual continuous process of acquiring an 
increasingly refined cognitive skill with potentially positive 
health-preserving effects [32]. 
The intricate relationship between psychic and physical 
levels in SFD is emphasized by the identification of a 
predominant pattern of lateralization of somatic symptoms 
correlated with emotional disorders. Min and Lee have 
studied patients with depressive, anxiety and somatization 
disorders (divided into two groups according to the 
laterality of somatic symptoms: either left or right) and 
found that the main somatic symptoms (especially 
headache, but also elsewhere localized pain) occur more 
frequently on the left side, with no significant differences 
among the left- and right-sided groups as to demographic 
variables (such as age, gender, marital status, Journal of Medicine and Life Vol. 2, No.4, October-December 2009 
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educational level), diagnosis, and duration of illness. 
Moreover, the anxiety and depression scores were higher 
in the left-sided group, without attaining statistical 
significance. The authors infer that the brain’s right 
hemisphere has more to do (than the left one) with the 
occurrence of emotionally conditioned somatization 
symptoms [33]. 
One cannot draw a neat boundary between 
somatoform symptoms and the so-called medically 
unexplained physical symptoms (MUPS). The MUPS may 
be considered as a variant of the somatoform disorders, 
from which they differ by a more diffuse, less 
differentiated nature. Hence the large overlap among the 
various syndromes classified as MUPS [34]. Some 
authors defined them as medical symptoms with no 
identifiable pathology and pointed out their relationship 
with psychiatric disorders, childhood and adulthood 
trauma, and personality traits [35], arguing that a 
paradigm change is mandatory in our approach to MUPS 
[36], all the more so as they are highly prevalent both in 
general population, and among individuals that frequently 
attend health care facilities [37]. The failure to provide 
medical explanations for such symptoms joined with the 
patients’ disturbed psychic background (which is 
intimately involved in the disease outcome) is conducive 
to the heavy demands put upon the health care system 
[38, 39]. An excessive amount of money is spent for the 
management of patients complaining of multiple MUPS 
(„polysymptomatic somatizers”), in whom the standard 
medical treatment is doomed to failure from the start and 
in whom the psychosocial interventions, although 
apparently beneficial, have not been proven to have a 
lasting and clinically significant impact [40].  
One problem is the patients’ refusal to admit 
psychosomatic explanations for their symptoms, 
understandable as many of them do not perceive a 
sufficiently strong correlation between their symptoms and 
their psychological states [41]. 
It is surmised that somatosensory amplification and 
alexithymia play an important predisposing role in the 
pathogenesis of MUPS. The somatosensory amplification 
is the tendency to report somatic sensations as being 
intense and worrisome, while alexithymia is a personality 
feature characterized by the subject’s difficulty to 
recognize his own emotions, paralleled by a tendency to 
focus upon external events and upon bodily sensations – 
the two phenomena are frequently correlated, both having 
an important role in psychosomatic patients [42]. The 
alexithymic individual may not be able to recognize the 
psychic impact of the stress and/or psychic distress 
generating circumstances [43]. He/she tends to displace 
his attention from those circumstances to the various 
somatic symptoms occurring in the context (with an 
ensuing increased tendency to be anxious and to report 
physical symptoms [44]). The result is his/her inclination 
to minimize the importance of therapeutically approaching 
the emotional disturbances. In such cases, focusing 
strictly upon the physical manifestations without granting 
due importance to the psychic trauma may render 
unfruitful the cure-aimed attempts [45]. Alexithymia has a 
recognized role in both medical and psychiatric disorders 
[46], some authorities considering it as a key element in a 
correct vision about the psychosomatic process, with a 
proven predictive value in somatizing patients [47], clearly 
related to the demands put upon the health care system 
[48] and to health behavior [49]. Although considered to 
be involved mainly in the genesis of SFD [50], alexithymia 
seems to play a role also in the psychogenesis of physical 
illnesses [51]. However, some studies provide only 
modest evidence for the role of alexithymia in predicting 
the advent of somatic symptoms in medically unexplained 
illnesses (such as chronic fatigue syndrome [52]) and or 
in predicting their persistence [53]. 
Nevertheless, there are opinions that MUPS cannot be 
considered exclusively psychic disorders, if one takes into 
account the fact that the most common somatic functional 
syndromes (among these: functional dyspepsia, irritable 
bowel syndrome, fibromyalgia, chronic fatigue syndrome, 
all of which might be put into the MUPS category), despite 
being related to depression and anxiety, are not entirely 
dependent on either of these [54]. 
The psychosomatic medicine suggests that the 
concept of distress/disorder/disease should include, 
generically and comprehensively, the whole range of 
disagreeable sensations/conditions experienced by the 
human being, from those on the mental-emotional level, 
to those on the physical one, including both functional 
symptoms (in which the disturbance affects only the 
physiology of the system, with no structural changes), and 
organic diseases (in which morphological alterations are 
apparent). In fact, the concept of disease should be 
envisaged as a continuum, if we take into account: 
• the different intermediate or borderline 
variants; 
•  the variable severity of organic lesions; 
•  the definition of nosological entities by 
alterations whose identification implies sophisticated 
tests, available only in specialized centers. 
The human being should be regarded as being in a 
continuous interaction with his/her environment, which 
might be viewed as a potential aggressor. For thousands 
of years until the middle of the last century, the 
environment’s assault had been predominantly on the 
physical level, with trauma and infectious diseases being 
the main cause of death. Only by the middle of the last 
century, the level of aggression shifted toward the 
psychoemotional level, as human society had become 
increasingly more sophisticated, imposing ever-higher 
standards to the individual (that is what we generically call 
psychosocial stress). Needless to say, this trend has been 
continuing since then.  
The response of the organism confronted with these 
(physical, chemical, biological, psychoemotional, social) 
assaults is to defend itself by putting into action, as a 
nonspecific mean, the inflammatory system, and, as a Journal of Medicine and Life Vol. 2, No.4, October-December 2009 
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specific mean, the immune system. Actually, the immune 
system may be regarded as an evolutionary requirement, 
since the reactions generated by the inflammatory system 
may endanger not only the aggressor’s integrity, but also 
that of the host organism, which it is actually supposed to 
protect (the actions of the two systems cannot be in fact 
dissociated). In the orchestration of these defense 
responses come into play the main coordination systems 
of the organism: the psychic, the nervous (primarily the 
autonomic one), and the endocrine. But the real switch of 
this response (the element which makes the link between 
the regulatory systems on one hand and the inflammatory 
and immune systems on the other hand) seem to be the 
cytokines.  
The nervous and endocrine systems have been for a 
long time regarded as an organic unity. Several 
neuroendocrine axes have been identified: hypothalamus-
pituitary-adrenal (HPA) axis, hypothalamus-adrenal 
medulla (HAM) axis, hypothalamus-pituitary-gonadal 
(HPG) axis. Among these, the HPA axis and the HAM 
axis have a decisive role in the organism’s response to 
stress – both affect and are affected by the production of 
cytokines: IL-1 and IL-6 stimulate the release of 
corticotropin-releasing hormone (CRH) from the 
hypothalamus via the eicosanoids pathway mediated by 
the cyclooxygenase [55], while the diurnal rhythm and 
exercise-induced changes in the plasma cortisol level 
differentially regulate the production of IL-1β, IL-6 and 
tumor necrosis factor-α (TNF-α): it has been shown that 
IL-6 production is highly sensitive to these changes, while 
the TNF-α production is comparatively resistant [56].  
The psychological modulation of the immune function 
through psychosocial stressful factors or through 
psychosocial therapeutic interventions may alter the 
health state [57]. The cytokines are an essential element 
in the bidirectional communication between the immune 
system and the brain. Understanding their role provides a 
critical insight in the influence behavior, mood and 
cognitive function exert upon the immune system [58]. 
Several mechanisms of the cytokines-brain interaction 
have been pointed out, relevant both for internal diseases, 
and for neurologic and psychiatric disorders [59, 60, 61].  
Moreover, the level of interleukins may be altered by 
affective, cognitive [62], behavioral factors, with 
implications in understanding the behavior and the 
immunopathology [63]. 
It is already known that the proinflammatory cytokines 
can influence the onset and the outcome of an entire 
spectrum of diseases (not only the cardiovascular ones) 
and that their action may have debilitating and disabling 
consequences. On the other hand, the output of 
proinflammatory cytokines may be directly stimulated by 
negative emotions and by stressful experiences (not only 
by chronic or relapsing infections). Accordingly, the 
disturbance of the immune regulation induced by 
emotional distress might be a key mechanism whereby 
the negative emotions jeopardize health. Therefore, 
psychoneuroimmunology has a broad range of 
implications for the fundamental biological sciences and 
for medicine.  
Revisiting the concept of the environment as an 
aggressor, one might consider it as appropriate when the 
individual is threatened by mechanical, physical, 
chemical, biological, and psychological potentially noxious 
agents/factors, but as inappropriate when neither of these 
is present and/or the individual is overreacting. This lack 
of adequacy may be envisaged as expression of a 
disturbed cognitive process, leading to an altered 
perception of the environment, and therefore to failed 
adaptation. 
Conclusions 
Several models of health and disease (evolutionary, 
biopsychosocial, psychophysiological, cognitive) have 
been elaborated in order to account for the role of 
psychosocial factors in the genesis of ill health. Each has 
its merits and its drawbacks, and a critical analysis may 
perceive all of them as part of a single, unifying vision. 
Somatization may be regarded as an altered cognitive 
process, inclining the individual to an amplified perception 
of the bodily sensations and of the negative experiences. 
Inappropriately perceiving the environment as an 
aggressor and excessively responding to it (by activating 
the cytokine system in correlation with the arousal of the 
psychic, nervous, and endocrine systems) may be a key 
element in the altered cognition conducive to ill health. 
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